Video - Ratio calculation of Aβ1-42 and Aβ1-40 offers essential information about the buildup of amyloid pathology in a patient's brain

Sep 20, 2021

Early and accurate diagnosis of Alzheimer's disease helps patients manage their condition and lifestyle.

In vitro analysis of a few drops of cerebrospinal fluid - or CSF - gives the clinician immediate diagnostic insights, through the measurement of the four main biomarkers currently used to help diagnose Alzheimer's disease.

This 2 minute video explains why and how a ratio calculation of the two amyloid proteins, Aβ1-42 and Aβ1-40, offers particularly essential information about the buildup of amyloid pathology in a patient's brain.

Read more about the use of the Aβ1-42/Aβ1-40 ratio to improve accuracy of Alzheimer's disease diagnosis in this guidance document. 

 

 

Subscribe to Fujirebio insight updates

Get all the latest insight articles from Fujirebio the moment they are published.

The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

Related articles

Related products

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.